Latest Farber Stories
Dana-Farber Cancer Institute scientists have successfully disrupted the function of a cancer gene involved in the formation of most human tumors by tampering with the gene's "on" switch and growth signals, rather than targeting the gene itself.
In a joint study, scientists from The Scripps Research Institute and Harvard University's Dana-Farber Cancer Institute have established a new class of anti-diabetic compound that targets a unique molecular switch.
BOSTON, July 21, 2011 /PRNewswire/ -- Zipcar, Inc. (Nasdaq: ZIP), the world's leading car-sharing network, is taking on the 32nd annual Pan-Massachusetts Challenge (PMC) with a team of 25 riders and a goal of raising $150,000 to support cancer research and treatment.
BRAINTREE, Mass., June 15, 2011 /PRNewswire/ -- Herman Lowe, who has been battling terminal brain cancer, Glioblastoma, for over two years, has written a free online book, "Brain Cancer: Beating the Odds" about his journey and what he has done to try to help others with this deadly disease.
BOSTON, March 24, 2011 /PRNewswire/ -- John Legere, CEO of Global Crossing, is nearing the finish line of his goal to raise $1 million for cancer research at Dana-Farber Cancer Institute.
QUINCY, Mass., Oct.
COLUMBIA, Md., Sept. 15 /PRNewswire-FirstCall/ -- Arbitron Inc. (NYSE: ARB) announced today that the Company's Board of Directors has re-appointed Erica Farber as a Director of Arbitron. Ms. Farber previously served as an Arbitron Director from March 2001 to July 2006.
Researchers say parents need opportunity to discuss concerns with caregivers
Men who have been treated for colorectal cancer can reduce their risk of dying from the disease by engaging in regular exercise.
UTRECHT, The Netherlands, November 2 /PRNewswire/ -- InteRNA Technologies B.V.
- totally perplexed and mixed up.